Kazuya Yamano

USPTO Granted Patents = 20 (Patent Applications = 1)

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 3 (Patent Applications = 2)

Average Co-Inventor Count = 9.3

ph-index = 8

Forward Citations = 448(Granted Patents)

Location History:

Tokyo, JP (2006)
Chiyoda-ku, JP (2012)
Machida, JP (2005 - 2019)

Company Filing History:

15 out of 272

Kyowa Hakko Kirin Co., Limited

patents

5 out of 730

Kyowa Hakko Kogyo Co., Ltd.

patents

Years Active: 2005-2019

Loading Chart...

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10233475 - Antibody composition-producing cell (2019-03-19),

2. 9409982 - Antibody composition-producing cell (2016-08-09),

3. 8895266 - Antibody composition-producing cell (2014-11-25),

4. 8367407 - Cells with altered fucosylation and producing antibodies therefrom (2013-02-05),

5. 8329443 - Antibody composition-producing cell (2012-12-11),

6. 8158760 - Glycoengineered, recombinant antibody (2012-04-17),

7. 8110195 - Antibody composition exhibiting cellular cytotoxicity due to glycosylation and containing ganglioside GM2 binding antibody (2012-02-07),

8. 8101185 - Anti-il-5 antibody composition exhibiting cellular cytotoxicity due to glycosylation (2012-01-24),

9. 8067232 - Antibody composition-producing cell with inactivated A-1,6-fusocyltransferase (2011-11-29),

10. 8039595 - Glycoengineered, recombinant antibody to CCR-4 with reduced fucosylation (2011-10-18),

11. 7858091 - Antibodies to insulin-like growth factor binding protein and uses thereof (2010-12-28),

12. 7846725 - Antibody composition-producing cell in which enzyme expression is inhibited by RNAi (2010-12-07),

13. 7741442 - Antibody composition exhibiting increased cellular cytotoxicity due to glycosylation (2010-06-22),

14. 7737325 - Antibody composition-producing cell (2010-06-15),

15. 7691810 - Method of producing recombinant antithrombin III composition (2010-04-06),

Title: Kazuya Yamano: Innovator in Antibody Production

Introduction

Kazuya Yamano, an accomplished inventor based in Machida, Japan, has made significant contributions to the field of biotechnology. With a remarkable portfolio of 20 patents, Yamano has focused primarily on innovative methods for antibody production, enhancing therapeutic strategies for various diseases.

Latest Patents

Among his latest inventions are notable patents related to antibody composition-producing cells. These patents describe innovative cells capable of producing antibody molecules, including those with high antibody-dependent cell-mediated cytotoxic activity. The inventions also encompass a detailed method for generating antibody compositions using these cells, as well as the end products and their applications in the medical field.

Career Highlights

Throughout his career, Kazuya Yamano has been affiliated with prominent companies such as Kyowa Hakko Kirin Co., Limited and Kyowa Hakko Kogyo Co., Ltd. His tenure at these organizations has allowed him to develop his expertise in biotechnology and contribute to significant advancements in antibody production technologies.

Collaborations

During his career, Yamano has collaborated with esteemed professionals in the industry, including Mitsuo Satoh and Yutaka Kanda. These partnerships have played a crucial role in furthering research and development in the realm of antibody therapeutics, leading to breakthroughs that benefit various medical applications.

Conclusion

Kazuya Yamano stands out as an innovative inventor whose work in antibody production has the potential to revolutionize treatments for numerous diseases. His contributions not only underscore his expertise but also illustrate the importance of collaboration in advancing biotechnological innovations. As the field continues to evolve, it is evident that inventors like Yamano will be at the forefront of driving meaningful change in healthcare.

This text is generated by artificial intelligence and may not be accurate.